MAP1LC3A and lung cancer: Autophagy is a major cellular process activated in NSCLC, and as previously reported by our group, specific patterns of MAP1LC3A (LC3A for simplicity) expression are related to poor prognosis, while the suppression of LC3A-mediated autophagy sensitizes lung cancer cells to radiotherapy and chemotherapy [10,11].